1
|
Gamal Sherif S, Tarek M, Gamal Sabry Y, Hassan Abou Ghalia A. Effect of apigenin on dynamin-related protein 1 in type 1 diabetic rats with cardiovascular complications. Gene 2024; 898:148107. [PMID: 38141690 DOI: 10.1016/j.gene.2023.148107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 12/02/2023] [Accepted: 12/20/2023] [Indexed: 12/25/2023]
Abstract
BACKGROUND AND OBJECTIVE Cardiovascular complications cause increased mortality rates among diabetics. The molecular mechanisms of aberrant mitochondrial dynamics in diabetes mellitus (DM) are not fully understood. Dynamin-related protein 1 (Drp1) is thought to be a major regulator of mitochondrial fission. There is lack of studies that examined the relationship between apigenin and Drp1 expression in DM. Thus, the current study aimed to explore the expression of Drp1 in diabetic rats with cardiovascular complications, as well as to appraise the role of apigenin in modulating this expression. METHODS Twenty-eight adult male albino Wister rats were randomly and equally allocated into four groups: naive, streptozotocin-induced type 1 diabetic control and two apigenin-injected diabetic groups (early and late). Body weight, heart weight, blood pressure and ECG were recorded. Evaluation of blood glucose level, lipid profile and cardiac functions were measured. Determination of Drp1 mRNA expression, and histological examination of cardiac tissues from the four groups were performed. RESULTS Diabetic control rats developed decrease of body weight, increase of blood pressure, deterioration of the normal ECG pattern and upregulation of Drp1 mRNA expression in cardiac tissues. There was a significant correlation between the relative expression of Drp1 and all examined parameters. Apigenin-injection improved fasting blood glucose, lipid profile and cardiac function indicators (i.e., ECG parameters, CK-MB and troponin) as well as the cardiac histological structure. The decrease of Drp1 expression was more evident with early than with late apigenin-injection, however, without statistical significance. CONCLUSIONS Increased level of Drp1 expression in diabetic rats may be involved in the pathogenesis of diabetic cardiovascular complications. The changes that occurred in response to apigenin injection highlight its potential ameliorative effect on the diabetic cardiovascular complications and pave the route for further investigations.
Collapse
Affiliation(s)
- Sara Gamal Sherif
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Egypt.
| | - Marwa Tarek
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Egypt.
| | | | - Azza Hassan Abou Ghalia
- Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University, Egypt.
| |
Collapse
|
2
|
Barras BJ, Ling T, Rivas F. Recent Advances in Chemistry and Antioxidant/Anticancer Biology of Monoterpene and Meroterpenoid Natural Product. Molecules 2024; 29:279. [PMID: 38202861 PMCID: PMC10780832 DOI: 10.3390/molecules29010279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2023] [Revised: 12/14/2023] [Accepted: 12/21/2023] [Indexed: 01/12/2024] Open
Abstract
Monoterpenes and meroterpenes are two large classes of isoprene-based molecules produced by terrestrial plants and unicellular organisms as diverse secondary metabolites. The global rising incidence of cancer has led to a renewed interest in natural products. These monoterpenes and meroterpenes represent a novel source of molecular scaffolds that can serve as medicinal chemistry platforms for the development of potential preclinical leads. Furthermore, some of these natural products are either abundant, or their synthetic strategies are scalable as it will be indicated here, facilitating their derivatization to expand their scope in drug discovery. This review is a collection of representative updates (from 2016-2023) in biologically active monoterpene and meroterpenoid natural products and focuses on the recent findings of the pharmacological potential of these bioactive compounds as well as the newly developed synthetic strategies employed to access them. Particular emphasis will be placed on the anticancer and antioxidant potential of these compounds in order to raise knowledge for further investigations into the development of potential anti-cancer therapeutics. The mounting experimental evidence from various research groups across the globe regarding the use of these natural products at pre-clinical levels, renders them a fast-track research area worth of attention.
Collapse
Affiliation(s)
| | - Taotao Ling
- Department of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA;
| | - Fatima Rivas
- Department of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA;
| |
Collapse
|
3
|
Sousa LDR, Viana NR, Coêlho AG, Barbosa CDO, Barros DSL, Martins MDCDCE, Ramos RM, Arcanjo DDR. Use of Monoterpenes as Potential Therapeutics in Diabetes Mellitus: A Prospective Review. Adv Pharmacol Pharm Sci 2023; 2023:1512974. [PMID: 38029230 PMCID: PMC10665111 DOI: 10.1155/2023/1512974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 09/06/2023] [Accepted: 11/04/2023] [Indexed: 12/01/2023] Open
Abstract
Monoterpenes are secondary metabolites of plants belonging to the terpenoid class of natural products. They are the most abundant components of essential oils that are generally considered to have various pharmacological properties. These compounds are reported to have antidiabetic effects in recent years. Due to nature's complex biosynthetic machinery, they also exhibit a reasonable degree of structural complexity/diversity for further analysis in structure-activity studies. Therefore, monoterpenes as antidiabetic agents have been investigated by recent in vitro and in vivo studies extensively reported in the scientific literature and claimed by patent documents. The purpose of this survey is to provide a comprehensive and prospective review concerning the potential applications of monoterpenes in the treatment of diabetes. The data for this research were collected through the specialized databases PubMed, Scopus, Web of Science, and ScienceDirect between the years 2014 and 2022, as well as the patent databases EPO, WIPO, and USPTO. The research used 76 articles published in the leading journals in the field. The main effect observed was the antidiabetic activity of monoterpenes. This review showed that monoterpenes can be considered promising agents for prevention and/or treatment of diabetes as well as have a marked pharmaceutical potential for the development of bioproducts for therapeutics applications.
Collapse
Affiliation(s)
- Leonardo da Rocha Sousa
- LAFMOL–Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piaui, Teresina, Brazil
- LaBME–Laboratory of Molecular Biology and Epidemiology, Federal Institute of Education, Science and Technology of Piauí–Campus Teresina Central, Teresina, Brazil
| | - Nildomar Ribeiro Viana
- LAFMOL–Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piaui, Teresina, Brazil
| | - Angélica Gomes Coêlho
- LAFMOL–Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piaui, Teresina, Brazil
| | - Celma de Oliveira Barbosa
- LAFMOL–Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piaui, Teresina, Brazil
| | | | - Maria do Carmo de Carvalho e Martins
- LAFMOL–Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piaui, Teresina, Brazil
| | - Ricardo Martins Ramos
- LaBME–Laboratory of Molecular Biology and Epidemiology, Federal Institute of Education, Science and Technology of Piauí–Campus Teresina Central, Teresina, Brazil
- LaPeSI–Information Systems Research Laboratory, Department of Information, Environment, Health and Food Production, Federal Institute of Piaui, Teresina, Brazil
| | - Daniel Dias Rufino Arcanjo
- LAFMOL–Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piaui, Teresina, Brazil
| |
Collapse
|
4
|
Raus de Baviera D, Ruiz-Canales A, Barrajón-Catalán E. Cistus albidus L.-Review of a Traditional Mediterranean Medicinal Plant with Pharmacological Potential. PLANTS (BASEL, SWITZERLAND) 2023; 12:2988. [PMID: 37631199 PMCID: PMC10458491 DOI: 10.3390/plants12162988] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 08/11/2023] [Accepted: 08/11/2023] [Indexed: 08/27/2023]
Abstract
Cistus albidus L. (Cistaceae) is a medicinal plant that has been used therapeutically since ancient times in the Mediterranean basin for its important pharmacological properties. The ability of C. albidus to produce large quantities of a wide range of natural metabolites makes it an attractive source of raw material. The main constituents with bioactive functions that exert pharmacological effects are terpenes and polyphenols, with more than 200 identified compounds. The purpose of this review is to offer a detailed account of the botanical, ethnological, phytochemical, and pharmacological characteristics of C. albidus with the aim of encouraging additional pharmaceutical investigations into the potential therapeutic benefits of this medicinal plant. This review was carried out using organized searches of the available literature up to July 2023. A detailed analysis of C. albidus confirms its traditional use as a medicinal plant. The outcome of several studies suggests a deeper involvement of certain polyphenols and terpenes in multiple mechanisms such as inflammation and pain, with a potential application focus on neurodegenerative diseases and disorders. Other diseases such as prostate cancer and leukemia have already been researched with promising results for this plant, for which no intoxication has been reported in humans.
Collapse
Affiliation(s)
- Daniel Raus de Baviera
- Department of Engineering, Area of Agroforestry, Miguel Hernández University, 03312 Orihuela, Spain; (D.R.d.B.); (A.R.-C.)
| | - Antonio Ruiz-Canales
- Department of Engineering, Area of Agroforestry, Miguel Hernández University, 03312 Orihuela, Spain; (D.R.d.B.); (A.R.-C.)
| | - Enrique Barrajón-Catalán
- Institute for Research, Development and Innovation in Health Biotechnology, Miguel Hernández University, 03202 Elche, Spain
- Department of Pharmacy, Elche University Hospital-FISABIO, 03203 Elche, Spain
| |
Collapse
|
5
|
Fraternale D, Dufat H, Albertini MC, Bouzidi C, D’Adderio R, Coppari S, Di Giacomo B, Melandri D, Ramakrishna S, Colomba M. Chemical composition, antioxidant and anti-inflammatory properties of Monarda didyma L. essential oil. PeerJ 2022; 10:e14433. [PMID: 36438580 PMCID: PMC9686412 DOI: 10.7717/peerj.14433] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 10/31/2022] [Indexed: 11/22/2022] Open
Abstract
In the present study, Monarda didyma L. essential oil (isolated from the flowering aerial parts of the plant) was examined to characterize its chemotype and to evaluate, in addition to the quali-quantitative chemical analysis, the associated antioxidant and anti-inflammatory activities. The plants were grown in central Italy, Urbino (PU), Marche region. Different analyses (TLC, GC-FID, GC-MS and 1H-NMR) allowed the identification of twenty compounds among which carvacrol, p-cymene and thymol were the most abundant. On this basis, the chemotype examined in the present study was indicated as Monarda didyma ct. carvacrol. The antioxidant effect was assessed by DPPH assay. Moreover, this chemotype was investigated for the anti-inflammatory effect in an in vitro setting (i.e., LPS-stimulated U937 cells). The decreased expression of pro-inflammatory cytokine IL-6 and the increased expression of miR-146a are suggestive of the involvement of the Toll-like receptor-4 signaling pathway. Although further studies are needed to better investigate the action mechanism/s underlying the results observed in the experimental setting, our findings show that M. didyma essential oil is rich in bioactive compounds (mainly aromatic monoterpenes and phenolic monoterpenes) which are most likely responsible for its beneficial effect.
Collapse
Affiliation(s)
- Daniele Fraternale
- Department of Biomolecular Sciences, University of Urbino, Urbino, PU, Italy
| | - Hanh Dufat
- Produits Naturels, Analyse et Synthèse, CITCOM-UMR CNRS 8038—Faculté de Santé, Pharmacie, Université Paris Cité, Université de Paris, Paris, France
| | | | - Chouaha Bouzidi
- Produits Naturels, Analyse et Synthèse, CITCOM-UMR CNRS 8038—Faculté de Santé, Pharmacie, Université Paris Cité, Université de Paris, Paris, France
| | - Rossella D’Adderio
- Department of Biomolecular Sciences, University of Urbino, Urbino, PU, Italy
| | - Sofia Coppari
- Department of Biomolecular Sciences, University of Urbino, Urbino, PU, Italy
| | - Barbara Di Giacomo
- Department of Biomolecular Sciences, University of Urbino, Urbino, PU, Italy
| | - Davide Melandri
- U. Burns Center, Dermatology and Emilia Romagna Regional Skin Bank, M. Bufalini Hospital, Cesena, FC, Italy
| | - Seeram Ramakrishna
- Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore
| | - Mariastella Colomba
- Department of Biomolecular Sciences, University of Urbino, Urbino, PU, Italy
| |
Collapse
|